 |
Articles: Drug/Product Alerts |
Mylan Receives FDA Approval for Generic Version of Migraine Treatment Imitrex
Mylan, 08/11/09
APP Pharmaceuticals Receives Approval for Idarubicin HCI Injection
American Pharmaceutical Partners, 08/11/09
Free full text
Sepracor Announces New Drug Submission to Health Canada for STEDESA as Adjunctive Treatment for Epilepsy
Sepracor, 08/11/09 Dronedarone (Multaq): Benzofuran derivative approved to reduce the risk of CV hospitalization in patients with AF
Formulary, 08/10/09 FDA Approves New 3000 IU Vial Size for Kogenate FS, antihemophilic factor (recombinant)
Bayer HealthCare Pharmaceuticals, 08/10/09
Free full text
Afinitor approved in EU as first treatment proven to benefit patients with advanced kidney cancer after failure of targeted therapy
Novartis, 08/07/09
Free full text
Guiding Your Drug Name to Approval
PharmExec, 08/07/09 Prasugrel: The newest platelet inhibitor has arrived
American Pharmacists Association, 08/06/09
Free full text
New Delivery System for RELISTOR in Pre-Filled Syringes Submitted for U.S. and European Marketing Approval
Wyeth, 08/06/09
Free full text
Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 25 MG and 50 MG
Watson Pharmaceuticals, 08/05/09
Free full text
CryoLife Receives CE Mark Approval for BioFoam Hemostatic Technology
Cryolife, 08/05/09
Free full text
Avastin approved in US for the most common type of kidney cancer
Roche, 08/04/09
Free full text
U.S. Food and Drug Administration Approves ONGLYZA (saxagliptin) for the Treatment of Type 2 Diabetes Mellitus in Adults
Bristol Myers-Squibb Company, 08/04/09
Free full text
FDA Approves Avastin for the Most Common Type of Kidney Cancer
Genentech, 08/04/09
Free full text
FDA Approves INVEGA SUSTENNA for the Acute and Maintenance Treatment of Schizophrenia
Janssen, 08/03/09
Free full text
INVEGA Approved as the First and Only Treatment for Schizoaffective Disorder
Janssen, 08/03/09
Free full text
U.S. Food and Drug Administration Approves ONGLYZA (saxagliptin) for the Treatment of Type 2 Diabetes Mellitus in Adults
Bristol Myers-Squibb Company, 08/03/09
Free full text
FDA Approves Expanded Use of ISENTRESS (raltegravir) in Combination Therapy for Adult Patients with HIV-1 Infection to Include Patients Not Previously Treated with HIV Medicines
Merck & Co., 08/03/09
Free full text
AstraZeneca submits New Drug Applications for ZACTIMA in second-line advanced non-small cell lung cancer
AstraZeneca, 07/31/09
Free full text
Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan
BioMarin, 07/31/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
143 Available Pages
|
|
